Histopathological and immunohistochemical study of oral lichen planus- associated HCV infection

European Journal of Internal Medicine

Volumn 11, Issue 5, 2000, Pages 277-282

  Nagao, Yumiko ^a   Sata, Michio ^a   Kage, Masayoshi ^a   Kameyama, Tadamitsu ^a   Ueno, Takato ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatitis C virus (HCV); Histopathological study; Oral lichen planus (OLP)

Indexed keywords

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LICHEN PLANUS; LIVER BIOPSY; LIVER FIBROSIS; LYMPHOCYTIC INFILTRATION; MALE; T LYMPHOCYTE;

EID: 0033802066     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(00)00107-2     Document Type: Article

References (51)

1. Pawlotsky J.M., Yahia M.B., Andre C., et al. Immunological disorders in C virus chronic active hepatitis: A prospective case-control study. Hepatology. 19:1994;841-848.
2. Misiani R., Bellavita R., Fenili D. et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med. 117:1992;573-577.
3. Ferri C., Greco F., Longombardo G., et al. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum. 34:1991;1606-1610.
4. Johnson R.J., Gretch D.R., Yamabe H. et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med. 328:1993;465-470.
5. Ohta S., Yokoyama H., Furuichi K., et al. Clinicopathologic features of glomerular lesions associated with hepatitis C virus infection in Japan. Clin Exp Nephrol. 1:1997;216-224.
6. Herrero C., Vinvente A., Bruguera M., et al. Is hepatitis C infection a trigger of porphyria cutanea tarda? Lancet. 341:1993;788-789.
7. Ferri C., Bacchi U., La Vista L., et al. Hepatitis C-related autoimmunity in patients with porphyria cutanea tarda. Eur J Clin Invest. 23:1993;851-855.
8. Hussain I., Hepburn N.C., Jones A., O'Rourke K., Hayes P.C. The association of hepatitis C viral infection with porphyria cutanea tarda in the Lothian region of Scotland. Clin Exp Dermatol. 21:1996;283-285.
9. Haddad J., Deny P., Munz-Gotheil C., et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet. 339:1992;321-323.
10. Koike K., Moriya K., Ishibashi K., et al. Sialadenitis histologically resembling Sjögren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci USA. 94:1997;233-236.
11. Scott C.A., Avellini C., Desinan L., et al. Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: comparison of Sjögren syndrome. Histopathology. 30:1997;41-48.
12. Wilson S.E., Lee W.M., Murakami C., Weng J., Moninger G.A. Mooren-type hepatitis C virus-associated corneal ulceration. Ophthalmology. 101:1994;736-745.
13. Moazami G., Auran J.D., Florakis G.J., Wilson S.E., Srinivasan D.B. Interferon treatment of Mooren's ulcers associated with hepatitis C. Am J Ophthalmol. 119:1995;365-366.
14. Ferri C., Caracciolo F., Zignego A.L., et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol. 88:1994;392-394.
15. Ferri C., La Civita L., Monti M., et al. Can type C hepatitis infection be complicated by malignant lymphoma? Lancet. 346:1995;1426-1427.
16. Sata M., Noguchi S., Ide T., et al. Lack of detection of hepatitis C virus replicative intermediate in abdominal lymph nodes. Hepatol Res. 10:1998;66-73.
17. Tanaka H., Tsukuma H., Teshima H., et al. Second primary cancers following non-Hodgkin's lymphoma in Japan: Increased risk of hepatocellular carcinoma. Jpn J Cancer Res. 88:1997;537-542.
18. Harada M., Sata M., Yoshida H., et al. Inflammatory myopathy associated with hepatitis C virus infection: a report of four cases. Int Hepatol Commun. 4:1995;195-200.
19. Matsumori A., Matoba Y., Sasayama S. Dilated cardiomyopathy associated with hepatitis C virus infection. Circulation. 92:1995;2519-2525.
20. Matsumori A., Matoba Y., Nishio R., Shioi T., Ono K., Sasatama S. Detection of hepatitis C virus RNA from the heart of patients with hypertrophic cardiomyopathy. Biochem Biophys Res Commun. 222:1996;678-682.
21. Matsumori A., Ohashi N., Sasayama S. Hepatitis C virus infection and hypertrophic cardiomyopahy. Ann Intern Med. 129:1998;749-750.
22. Okabe M., Fukuda K., Arakawa K., Kikuchi M. Chronic variant of myocarditis associated with hepatitis C virus infection. Circulation. 96:1997;22-24.
23. Jubert C., Pawlotsky J.M., Pouget F., et al. Lichen planus and hepatitis C virus-related chronic active hepatitis. Arch Dermatol. 130:1994;73-76.
24. Gandolfo S., Carbone M., Carrozzo M., Gallo V. Oral lichen planus and hepatitis C virus (HCV) infection: is there a relationship? A report of 10 cases. J Oral Pathol Med. 23:1994;119-122.
25. Bagan J.V., Aguirre J.M., del Olmo J.A., et al. Oral lichen planus and chronic liver disease: clinical and morphometric study of the oral lesions in relation to transminase elevation. Oral Surg Oral Med Oral Pathol. 78:1994;337-342.
26. Nagao Y., Sata M., Tanikawa K., Itoh K., Kameyama T. Lichen planus and hepatitis C virus in the Northern Kyushu region of Japan. Eur J Clin Invest. 25:1995;910-914.
27. Bellman B., Reddy R.K., Falanga V. Lichen planus associated with hepatitis C. Lancet. 346:1995;1234.
28. Carrozzo M., Gandolfo S., Carbone M., et al. Hepatitis C virus infection in Italian patients with oral lichen planus: a prospective case-control study. J Oral Pathol Med. 25:1996;527-533.
29. Nagao Y., Sata M., Tanikawa K., Itoh K., Kameyama T. High prevalence of hepatitis C virus antibody and RNA in patients with oral cancer. J Oral Pathol Med. 24:1995;354-360.
30. Nagao Y., Sata M., Itoh K., et al. High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma. Hepatol Res. 7:1997;206-212.
31. Kirby A.C., Lodi G.L., Olsen I., Porter S.R. Immunohistochemical and serological comparison of idiopathic and hepatitis C virus-associated forms of oral lichen planus. Eur J Oral Sci. 106:1998;853-862.
32. Tanei R., Watanabe K., Nishiyama S. Clinical and histopathological analysis of the relationship between lichen planus and chronic hepatitis C. J Dermatol. 22:1995;316-323.
33. Ichida F., Tsuji T., Omata M., et al. New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun. 6:1996;112-119.
34. Nagao Y., Sata M., Fukuizumi K., Tanikawa K., Kameyama T. High incidence of oral precancerous lesions in a hyperendemic area of hepatitis C virus infection. Hepatol Res. 8:1997;173-177.
35. Nagao Y., Sata M., Itoh K., Tanikawa K., Kameyama T. Quantitative analysis of HCV RNA and genotype in patients with chronic hepatitis C accompanied by oral lichen planus. Eur J Clin Invest. 26:1996;495-498.
36. Logi G., Carrozzo M., Hallett R., et al. HCV serotypes in Italian patients with HCV-related oral lichen planus. J Oral Pathol Med. 26:1997;381-384.
37. Pawlotsky J.M., Benchiki H., Pellet C., et al. Lichen planus and hepatitis C virus (HCV)-related chronic hepatitis: evaluation of HCV genotypes. Br J Dermatol. 133:1995;666-667.
38. Nagao Y., Sata M., Tanikawa K., Kameyama T. Immunological evaluation in oral lichen planus with chronic hepatitis C. J Gastroenterol. 32:1997;324-329.
39. Protzer U., Ochsendorf F.R., Leopolder-Ochsendorf A., Holtermuller K.H. Exavation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C. Gastroenterology. 104:1993;903-905.
40. Nagao Y., Sata M., Ide T., et al. Development and exacerbation of oral lichen planus during and after interferon therapy for hepatitis C. Eur J Clin Invest. 426:1996;1171-1174.
41. Lapidoth M., Arber N., Ben Amitai D., Hagler J. Successful interferon treatment for lichen planus associated with chronic active hepatitis due to hepatitis C virus infection. Acta Dermatol Venereol. 77:1997;171-172.
42. Nagao Y., Sata M., Suzuki H., Kameyama T., Ueno T. Histologic improvement of oral lichen planus in patients with chronic hepatitis C treated with interferon. Gastroenterology. 117:1999;283-284.
43. Nagao Y., Sata M., Tanikawa K., Kameyama T. A case of oral lichen planus with chronic hepatitis C successfully treated by glycyrrhizin. Kansenshogaku Zasshi. 69:1995;940-943.
44. Nagao Y., Sata M., Suzuki H., Tanikawa K., Itoh K., Kameyama T. Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection. J Gastroenterol. 31:1996;691-695.
45. Nagao Y., Sata M., Kameyama T. Hepatitis C virus RNA detection in oral lichen planus tissue. Am J Gastroenterol. 93:1998;850.
46. Nagao Y., Sata M., Noguchi S., Seno'o T., Kinoshita M., Kameyama T., Ueno T. Detection of hepatitis C virus RNA in oral lichen planus and oral cancer tissues. J Oral Pathol Med. 29:2000;259-266.
47. Nagao Y., Sata M., Noguchi S., et al. GB virus infection in patients with oral cancer and oral lichen planus. J Oral Pathol Med. 26:1997;138-141.
48. Regezi J.A., Deegan M.J., Hayward J.R. Lichen planus: Immunologic and morphologic identical of the submucosal infiltrate. Oral Surg. 46:1978;44-52.
49. Dockrell H.M., Greenspan J.S. Histochemical identification of T cells in oral lichen planus. Oral Surg. 48:1979;42-46.
50. Zinkernagel R.M., Haenseler E., Leist T., Cerny A., Hengartner H., Althage A. T cell mediated hepatitis in mice infected with lymphocytic choriomeningitis virus: Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay? J Exp Med. 164:1986;1075-1092.
51. Fujii H., Hiketa T., Matsumoto Y., et al. Clinical characteristics of chronic cutaneous graft-versus-host disease in Japanese leukemia patients after bone marrow transplantation: low incidence and mild manifestations of skin lesions. Bone Marrow Transplant. 10:1992;331-335.